Interne link ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform december 22, 2022 om 11:15 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 november 14, 2022 om 09:30 PM UTC
Interne link ProQR Announces Third Quarter 2022 Operating and Financial Results november 09, 2022 om 12:00 PM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference november 03, 2022 om 11:00 AM UTC
Interne link ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs augustus 11, 2022 om 11:00 AM UTC
Interne link ProQR Announces Second Quarter 2022 Operating and Financial Results augustus 04, 2022 om 11:00 AM UTC
Interne link ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium juni 28, 2022 om 11:00 AM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates juni 01, 2022 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 mei 09, 2022 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2022 Operating and Financial Results mei 05, 2022 om 08:30 PM UTC
Interne link ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022 april 26, 2022 om 08:10 PM UTC
Interne link ProQR to Participate in the Kempen Life Sciences Conference april 19, 2022 om 08:30 PM UTC
Interne link ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy april 13, 2022 om 11:00 AM UTC
Interne link ProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit april 04, 2022 om 11:00 AM UTC
Interne link ProQR to Participate in the Cantor Virtual Rare Orphan Disease Summit maart 23, 2022 om 08:30 PM UTC
Interne link ProQR Appoints John Maraganore, PhD, as Strategic Advisor to the Supervisory Board maart 07, 2022 om 12:00 PM UTC
Interne link ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results februari 24, 2022 om 12:00 PM UTC
Interne link ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10 februari 11, 2022 om 12:00 PM UTC
Interne link ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen januari 04, 2022 om 12:00 PM UTC
Interne link ProQR Therapeutics Added to NASDAQ Biotechnology Index december 24, 2018 om 12:00 PM UTC
Interne link ProQR annonce la publication dans Nature Medicine des données du QR-110 pour l’amaurose congénitale de Leber 10 december 18, 2018 om 03:27 PM UTC
Interne link ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10 december 17, 2018 om 04:52 PM UTC
Interne link ProQR Announces Strategic Changes to the Management Team and Key New Hires december 13, 2018 om 12:00 PM UTC